News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Marken (Formerly known as Marken Time Critical) Announces Global Advisory Board


6/22/2012 11:13:25 AM

RESEARCH TRIANGLE PARK, N.C., June 21, 2012 /PRNewswire/ -- Marken announced today the first Marken Global Advisory Board, held on June 19, 2012. As the leader in global life science supply chain management, Marken continues to be the forerunner for promoting industry trends and innovation as well as establishing international best practices.  This strategic and technical board of global advisors was hand-picked to provide Marken clients evolving industry knowledge and perspectives for regulatory, temperature sensitive, clinical specimen aspects of the end to end Pharmaceutical Supply Chain.  The internationally recognized experience of the advisory board positions Marken to provide consulting and leadership to its clients globally and will represent Marken as opinion leaders.

(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

Advisory Board Members:

Rafik H. Bishara, PhD is the current Chair of the Pharmaceutical Cold Chain Interest Group (PCCIG) within the Parenteral Drug Association PDA) formerly Director, Quality Knowledge Management and Technical Support with Eli Lilly & Co. for 35+ years.

Laurent Foetisch is Founder and Managing Director of Supply Chain Operations SA, formerly Vice President of Global Supply Chain for Merck Serono and Serono for over 20 years.

Alan Horgan is an independent consultant working with Whiteacres Associates LLC and formerly Group Vice President, Late Stage Development MDS Pharma Services and Corporate Senior Vice President & Global President of Clinical Development for Covance.

Hedley Rees is Managing Consultant, Biotech PharmaFlow expert in Lean Thinking and Production Systems.  Hedley is a strong advocate of the regulatory modernization frameworks of FDA's 21st Century Modernization and ICH Q8 Q11.

"The drive, passion and energy of this new Global Advisory Board will not only propel Marken to new levels, but will also ensure higher standards of patient care by forging new industry expectations for supply chain service.  It's exciting to be setting this stage for not only our current markets, but in areas of the world that need this type of leadership to better serve their investigator sites and ultimately, the patient." said Wes Wheeler, CEO. 

About Marken

Marken is the leading global clinical supply chain solutions provider dedicated 100% to the pharmaceutical and life sciences industries, supporting over 49,000 investigator sites in more than 150 countries. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.

SOURCE Marken


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES